Blog Hero

#79: What do we know about Atropine! with Mark Bullimore and Patrick Johnson from Syndexis

Our Newsletter

I want to give a special thank you to Syndexis for being a sponsor of The Myopia Podcast. If you're not aware Syndexis is a biopharmaceutical company that was founded in 2014, they're based in Del Mar California.
Their mission is to develop a proprietary stable accurate effective
safe topical eye drop to treat the progression of myopia in children
and to minimize the risk of co-morbidities later in life. They're on the cusp of a new treatment paradigm to fight myopia progression in children, they're in the late stage of their pivotal phase 3 trial for their investigation medication SYD1 01.

The Myopia Podcast and myself are rooting for them and are watching Syndexis closely. 
Stay tuned!

Written by

More Articles By

The Most Recent Podcast

Start Listening Today

Collaborate with Us

Myopia management is an ever-evolving field, and Dr. Kading strongly believes in collaboration to develop and discuss new ideas with respected voices around the world. 

If you’re interested in consulting with Dr. Kading, please feel free to connect with us to discuss new opportunities and professional development. 

Contact us today to get in touch with Dr. Kading.

Downloadable E-Guides

The Myopia Handbook is coming soon! 

When you sign up, you’ll get access to informative myopia management content designed to make complex concepts accessible and relatable. The Myopia Handbook by Dr. David Kading is an essential guide for eye care professionals navigating the field of myopia management.

We will store all future e-guides here, and all you have to do is sign up to access them.

instagram facebook facebook2 pinterest twitter google-plus google linkedin2 yelp youtube phone location calendar share2 link star-full star star-half chevron-right chevron-left chevron-down chevron-up envelope fax